From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Keyword results: SIS

SIS
SIS

Science in Sport – emphasises “growth and efficiency plan” and trading momentum “gathering”, but what about cash flow?

‘Performance nutrition company’ Science in Sport (SIS) has announced what it states is “an ambitious growth and efficiency plan”and that on trading “momentum is gathering”. So what of a current share price up to 9p, giving a £15.5 million market capitalisation?
Bearcast
PREMIUM CONTENT

Tom Winnifrith Bearcast – Back at 3.30 AM from the Northern Ireland game

I share a few thoughts with you - truths one cannot say in public - about the game last night. Notwithstanding that, I enjoyed the match, and the Northern Ireland girls held their heads up. Then, I discuss Canadian Overseas Petroleum (COPL), explaining my Christmas sub-10p target - the shares really will halve from here. I look at Shield Therapeutics (STX), MGC Pharmaceuticals (MXC), and Science in Sport (SIS) which, at every level, looks a stinker - even after today's 22% fall, the shares are grotesquely overvalued. I explain why. Finally, I describe why Malcolm should have learned from IQE (IQE) before continuing to tip Zoo Digital (ZOO) - as he has again done, today.

Subscribe to ShareProphets to access Premium Content
SIS
SIS

Science in Sport – shares bouncing on placing, but...

‘Performance nutrition company’ Science in Sport (SIS) “is pleased to announce the completion of the placing… raising gross proceeds of approximately £4.5 million… at a price of 37 pence per share” – and the shares have currently responded up to around 40p...

SIS
SIS

Science in Sport – trading update, valuation as well as its nutrition products “premium”?

Self-styled “the premium performance nutrition company serving elite athletes, sports enthusiasts and the gym lifestyle community”, Science in Sport (SIS) has updated commencing “2019 has seen rapid progress at the company… total sales growth for the year to 31 December 2019 is expected to be slightly ahead of market expectations, with sales momentum into 2020 underpinned by operational progress including a new PhD.com e-commerce platform and a new protein powder line, which is now in full production”. Sounds encouraging…

SIS
SIS

Science in Sport – a “trading update” which omits to update on the bottom-line impact of trading!

Sports nutrition company Science in Sport (SIS) has made a “Pre-Close Trading Update” announcement commencing that “sales increased 30% to £12.24 million in the 12 months to 31 December 2016”. Sounds promising, what about profitability?…

SIS
SIS

Science in Sport: Cashed up and ready to go

I tipped Science in Sport (SIS) last month following the announcement of an exciting tie-up with Liverpool FC. This morning sees the release of the company’s interim results, confirming excellent progress made and with good omens for future profitability.

SIS
SIS

Science in Sport: Unprofitable but with bags of potential: BUY

It’s not every day that I find a small-cap which I think has the potential for serious growth, but I think I may be looking at one in the form of Science in Sport, or “SiS” (SIS). The company has announced this morning that it is set to become the Official Sports Nutrition Partner for Liverpool football this season, in a move which should further raise its profile.

Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments

Time left: 12:17:38